Gennex Laboratories has announced the resignation of Ms. Shilpa Bung from her position as Non-Executive Independent Women Director, effective February 14, 2026. The resignation was tendered with immediate effect and was formally accepted by the Board of Directors during their meeting held on the same date.

Reason for Resignation

Ms. Bung's decision to step down stems from her recent election as Chairperson of the CS Hyderabad Chapter. In her resignation letter, she explained that this new leadership position demands significant time commitment and responsibilities that would preclude her continued active participation on Gennex Laboratories' Board.

Director Details and Compliance

Ms. Bung has confirmed that there are no other material reasons for her resignation beyond those mentioned in her resignation letter, as required under regulatory guidelines.

Other Directorships

The departing director currently holds independent director positions in two other listed entities:

• Sigachi Laboratories Limited
• Godavari Drugs Limited

Ms. Bung has also requested to be relieved from all Board Committees of which she was a member.

Regulatory Compliance

The resignation has been reported in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has fulfilled all necessary disclosure requirements and uploaded the intimation on its website at www.gennexlab.com .

In her resignation letter, Ms. Bung expressed gratitude to the Board and management for the opportunity to serve and contribute to the company's growth during her tenure as Independent Director.

Gennex Laboratories Limited announced the appointment of Ms. Khushbu Kachhawa as Additional Non-Executive Independent Women Director, effective February 14, 2026. The appointment was approved by the Board of Directors based on the recommendation of the Nomination & Remuneration Committee and is subject to shareholder approval.

Director Appointment Details

Ms. Khushbu Kachhawa brings professional expertise to the board with her educational background and experience in corporate affairs. The appointment strengthens the company's board composition and governance structure.

Professional Background

Ms. Kachhawa has approximately 5 years of experience in handling business affairs and corporate secretarial matters. She is not related to any Directors or Key Managerial Personnel of the company and fulfills the criteria required under the provisions of the Companies Act, 2013 and the Listing Regulations.

Regulatory Compliance

The appointment has been made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ms. Kachhawa is not debarred from holding the office of director by virtue of any SEBI order or any other authority. The company has filed the necessary disclosures including Form B under the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Corporate Governance Enhancement

This appointment is part of Gennex Laboratories' ongoing commitment to strengthening its corporate governance framework. The addition of an independent women director aligns with regulatory requirements and enhances board diversity. The pharmaceutical company, which specializes in bulk drugs manufacturing including Guaifenesin and Methocarbamol, continues to focus on maintaining robust governance standards alongside its operational growth.